Response to Comments: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia

No policy body was provided for A54894 beyond the title and brief description, so specific coverage indications, limitations, documentation requirements, and frequency limits cannot be extracted. The document pertains to Noridian's response to comments on MolDX genetic testing for hypercoagulability/thrombophilia; obtain the full policy text to perform a complete, high-confidence extraction.

"Full policy content not provided in request; obtain the complete Noridian Response to Provider Recommendations (MolDX: Genetic Testing for Hypercoagulability/Thrombophilia) to extract required docu..."

Sign up to see full coverage criteria, indications, and limitations.